New York Langone — New York, New York

New York Langone is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

New York Langone has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Glioblastoma, GBM.

Sponsors: Alpheus Medical, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Langone?

New York Langone has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Langone conducted?

New York Langone has 1 clinical trials on record, with 1 currently active. Their work covers Glioblastoma, GBM.

Is New York Langone accredited by Crixeo Health?

New York Langone has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Langone?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.